Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > PEA assumptions

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon May 04, 2024 1:04pm

79 Views

Post# 36023318

RE:PEA assumptions

Year 1 market penetration ~ 10%.....

Year	Base Case	Case 1
Mkt penetration	30% NA, 15% Europe	50% NA, 15% Europe
	SmoothX bottles	SmoothX bottles
1	5,600,000	8,267,000
2	15,000,000	19,000,000
3	18,000,000	22,000,000
4	18,000,000	22,000,000
5	18,000,000	22,000,000
6	18,000,000	22,000,000
7	18,000,000	22,000,000
8	18,000,000	22,000,000
9	18,000,000	22,000,000
10	10,500,000	12,833,000
Totals	157,100,000	194,100,000